REQUEST A DEMO
Total
USD $0.00
Search more companies

Vifor Pharma Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Wholesale Trade
Full name: Vifor Pharma Asia Pacific Pte. Ltd. Profile Updated: April 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Vifor Pharma Asia Pacific Pte. Ltd. is based in Singapore. The head office is in Singapore. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on July 01, 2008. Vifor Pharma Asia Pacific Pte. Ltd. currently employs Below 50 (estimated) people. There was a net sales revenue increase of 3.12% reported in Vifor Pharma Asia Pacific Pte. Ltd.’s latest financial highlights for 2025. Its’ total assets recorded a growth of 4.06%. The net profit margin of Vifor Pharma Asia Pacific Pte. Ltd. decreased by 1.57% in 2025.

Legal Address
20 Mccallum Street, #20-01, Tokio Marine Centre, Singapore 069046
Singapore; Singapore; Postal Code: 069046

Contact Details: Purchase the Vifor Pharma Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Vifor Pharma Asia Pacific Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Vifor Pharma Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Vifor Pharma Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
July 01, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vifor Pharma Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
3.12%
Total Operating Revenue
3.12%
Net Profit/Loss for the Period
-20.21%
Total Assets
4.06%
Total Equity
12.72%
Net Profit Margin
-1.57%
Return on Equity (ROE)
-2.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?